You can count on Simparica to prevent or quickly eliminate home flea infestations.
Delivers proven results
Simulation of Flea-infested Home Environment
- Simparica administered monthly for 3 months demonstrated >95.6% reduction in adult fleas within 14 days of treatment and reached 100% from day 60 to day 90, the end of the study.1
Breaks the flea life cycle
- Simparica kills adult fleas before they can lay eggs. In a lab experiment, dogs were infested with fleas and then treated with Simparica. One day after treatment, no viable eggs were produced by fleas. This effect continued through the entire observation period of 35 days.1
IMPORTANT SAFETY INFORMATION
Simparica is for use only in dogs, 6 months of age and older. Simparica may cause abnormal neurologic signs such as tremors, decreased conscious proprioception, ataxia, decreased or absent menace, and/or seizures. Simparica has not been evaluated in dogs that are pregnant, breeding or lactating. Simparica has been safely used in dogs treated with commonly prescribed vaccines, parasiticides and other medications. The most frequently reported adverse reactions were vomiting and diarrhea. See full Prescribing Information.
1. Six RH, Becskei C, Carter L, et al. Evaluation of the speed of kill, effects on reproduction, and effectiveness in a simulated infested-home environment of sarolaner (Simparica™) against fleas on dogs. Vet Parasitol. 2016;222:23–27.
This site is intended for U.S. Animal Healthcare Professionals.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2017 Zoetis Services LLC. All rights reserved. SMP-00181
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States